Compare Eaton Corporation plc (ETN) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs McKesson Corporation — how do they compare? Eaton Corporation plc trades at $426.17 (market cap $164.88B), while McKesson Corporation trades at $933.06 (market cap $108.46B). The key difference: Eaton Corporation plc is the larger of the two by market cap, and Eaton Corporation plc pays the higher dividend (1.04%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and McKesson Corporation for 74 Days on average.
| ETN | MCK | |
|---|---|---|
Market Cap | $164.88B | $108.46B |
Volume | 2,535,086 | 712,607 |
Sector | Industrials | Health |
52-Week High | $459.96 | $995.69 |
52-Week Low | $315.82 | $725.17 |
Typical Hold Time | 31 Days | 74 Days |
Enterprise Value | $185.51B | $115.00B |
Dividend Yield | 1.04% | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 70% buy ratings. The company shows consistent earnings beats and robust profitability with 12.75% net margins. Technical indicators suggest a bullish trend with support at $426 and resistance at $434. Recent acquisitions in data center and utility markets position ETN for durable growth in key infrastructure sectors.
Outlook remains positive with a $502.38 consensus price target representing 16% upside. Key opportunities include data center demand and grid modernization, while risks involve execution of recent acquisitions and potential market volatility. The company's strong backlog and strategic positioning in high-growth infrastructure markets support continued investor confidence.
McKesson (MCK) trades at $910.33, down 1.23% over 24 hours, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue grew to $359.05 billion in 2025, though net margins remain thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing growth visibility in pharmaceutical distribution.
The outlook remains positive given analyst consensus favoring Buy ratings (80.65%) and a price target of $956.43, implying ~5% upside. Risks include margin pressure from drug pricing dynamics and policy uncertainty, while institutional accumulation and solid cash flow generation support stability. Earnings momentum and strategic partnerships position MCK for sustained growth, though investors should monitor competitive and regulatory headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
